668-22215-86099
2 vaccinations
2 coded responses
20 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 660 / KS
- Registered
- 2021-02-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-02-07
Registered in v-safe
- 2021-02-08
- 2021-02-10
- 2021-02-11
- 2021-02-13
- 2021-02-20
-
2021-02-27
Dose 2 — Pfizer-BioNTech
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-12
- 2021-05-29
-
2021-08-28
Survey response — 6 months, dose 2MedDRA: Giant cell arteritis, Hospitalisation, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diagnosed with temporal arteritis and placed on high dose prednisone. Aug 5 2021 Now isolated from all unvaccinated people. I had 2 negative COVID PCR tests during hospitalization and on Aug 19 2021pre temporal artery biopsy onMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-27
Survey response — 12 months, dose 2MedDRA: Giant cell arteritis, Interstitial lung disease, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Symptoms: Giant cell arteritis. Negative stroke and tumor work up. High dose prednisone on taper and starting Actemra this week. Chronic stage 3 renal failure. Fibrotic interstitial lung disease discovered in process of prep for Actemra PFT good. · Healthcare visit (other): Followed by pulmonary neuro rheumatologyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-27
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-03-01
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with temporal arteritis and placed on high dose prednisone. Aug 5 2021 Now isolated from all unvaccinated people. I had 2 negative COVID PCR tests during hospitalization and on Aug 19 2021pre temporal artery biopsy on
Release 11 — 12 months, dose 2
Symptoms: Giant cell arteritis. Negative stroke and tumor work up. High dose prednisone on taper and starting Actemra this week. Chronic stage 3 renal failure. Fibrotic interstitial lung disease discovered in process of prep for Actemra PFT good.
Healthcare visit (other): Followed by pulmonary neuro rheumatology
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Giant cell arteritis | ✓ | · | ✓ |
| SD | Hospitalisation | ✓ | · | ✓ |
| SD | Interstitial lung disease | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release